The Feinstein Institutes for Medical Research, part of Northwell Health, and Cold Spring Harbor Laboratory (CSHL) recently launched a fully virtual clinical trial to evaluate the safety and efficacy of...
AstraZeneca recently announced that its COVID-19 vaccine is safe and effective at preventing coronavirus in Phase 3 clinical trials from the UK, Brazil, and South Africa.
The first dose of...
Eli Lilly and Company recently announced that its COVID-19 neutralizing antibodies reduced coronavirus-related hospitalizations and deaths in high-risk patients by 70 percent in a Phase 3...
Eli Lilly and Company, Vir Biotechnology, and GSK recently collaborated to evaluate a combination of two COVID-19 therapies in low-risk patients with mild to moderate coronavirus.
Eli Lilly and...
Pfizer and BioNTech recently announced an advanced purchase agreement with COVAX for up to 40 million doses of its mRNA COVID-19 vaccine, BNT162b2.
The first doses of the vaccine are expected to be...
Johnson & Johnson recently announced that a single-dose of its COVID-19 vaccine candidate, Ad26.COV2.S, was 66 percent effective at preventing moderate to severe coronavirus in a Phase 3 clinical...
Novavax recently announced that its COVID-19 vaccine candidate, NVX-CoV2373, was 89.3 percent effective in the Phase 3 UK clinical trial.
The trial also found that the vaccine was 95.6 percent...
President Joe Biden recently signed an executive order to accelerate the development of novel COVID-19 therapies and improve access to care for all Americans.
First, Biden called on the HHS and...
Moderna recently announced that clinical trial researchers have dosed the first in the Phase 1/2 study of its mRNA COVID-19 vaccine, mRNA-1273, in Japan, led by Takeda Pharmaceuticals.
The...
Thermo Fisher Scientific recently announced that it entered into a $450 million definitive agreement to acquire San Diego-based Mesa Biotech, Inc. and boost the availability of reliable molecular...
Merck recently announced that it is discontinuing development of its COVID-19 vaccine candidates, V590 and V591, and will focus its research strategy on advancing its two other candidates, MK-4482 and...
Pfizer and BioNTech recently announced that its COVID-19 vaccine, BNT162b2, elicited antibodies that neutralize the SARS-CoV-2 UK strain, known as B.1.1.7 lineage.
The in-vitro study...
The US will remain a member of the World Health Organization (WHO) under President Joe Biden and will join COVAX, a global COVID-19 vaccine program led by WHO, NIAID Director Anthony Fauci, MD, said in...
Future industry-wide trends for pharmaceutical companies and manufacturers are taking root as the industry continues to respond to the COVID-19 pandemic.
Listen to the full podcast to hear...
President Joe Biden recently signed an executive order to combat COVID-19 and prepare for future biological and pandemic threats.
“The Federal Government must act swiftly and aggressively...
Janet Woodcock will be stepping in as Acting FDA Commissioner while the Biden administration finalizes a nominee for the position.
Woodcock will replace Stephen M. Hahn, MD, after he resigned last...
Recently, experts have considered delaying, skipping, or half-dosing Moderna and Pfizer-BioNTech’s COVID-19 vaccines to reach more people in need and create a more wide-spread...
Vir Biotechnology and GSK recently announced an agreement with UK-based AGILE initiative to evaluate the company’s COVID-19 antibody, VIR-7832, in a Phase 1b/2a clinical trial.
The AGILE trial...
Moderna recently announced that Swissmedic, the Swiss Agency for therapeutic products, has authorized its mRNA-based COVID-19 vaccine for use in Switzerland.
The Swiss authorization comes over a month...
COVID-19 vaccine distribution has begun across the country. But government officials are not the only ones making difficult decisions about the logistics of vaccine rollout. Health system leaders must...
